Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 19: 294-300, 1973;
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Heremans, J. F.
Right arrow Articles by Masson, P. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Heremans, J. F.
Right arrow Articles by Masson, P. L.

Clinical Chemistry, Vol 19, 294-300, Copyright © 1973 by the American Association for Clinical Chemistry

Specific Analysis of Immunoglobulins. Techniques and Clinical Value

Joseph F. Heremans 1 and Pierre L. Masson 1

1 Department of Experimental Medicine, The University of Louvain, Avenue Chapelle-aux-Champs 4, B-1200 Brussels, Belgium.

We recommend that routine screening of sera for immunoglobulin disorders consist of a combination of electrophoresis in agarose and immunochemical quantitation of serum IgG, IgA, and IgM. Abnormalities detected by this procedure may be classified as (a) immune deficiencies, (b) polyclonal hyperimmunoglobulinemias, or (c) monoclonal immunoglobulin disorders. The analyst can contribute to the diagnosis of immune deficiency by detecting evidence for plasma protein losses in the urine, unsuspected monoclonal immunoglobulin disorders, and abnormalities in the immunoglobulin content and spectrum of secretions. Polyclonal hyperimmunoglobulinemia —seen in infections, autoimmune disease, liver disease, sarcoidosis, or other conditions—is frequently associated with an imbalance between the different immunoglobulin classes, and with the appearance of discrete inhomogeneities in the immunoglobulin zones of the electrophoretic spectrum. Factors involved in this process are listed, and examples are indicated. Monoclonal immunoglobulin disorders may not be detected if the tumor protein is masked by normal serum-protein fractions or misdiagnosed by confusion with nonimmunoglobulin components. Diagnosis of immunocyte malignancy is aided by detection of Bence Jones protein in the urine; measurements of serum IgG, IgA, and IgM concentrations; and monitoring the concentration of the abnormal component in the serum as the disease evolves.


Key Words: IgG, IgG, IgM • Bence Jones protein • diagnostic aid • Electrophoresis in agarose gel • routine screening for immunologic disorders • electrophoresis of urine

Submitted on November 7, 1972
Accepted on November 16, 1972






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1973 by the American Association for Clinical Chemistry.